Contribution of Maternal Copy Number Variations to False-Positive Fetal Trisomies Detected by Noninvasive Prenatal Testing.

Xiya Zhou,Lili Sui,Yalan Xu,Yijun Song,Qingwei Qi,Jianguang Zhang,Hongmin Zhu,Huaiyu Sun,Feng Tian,Mengnan Xu,David S. Cram,Juntao Liu

DOI: https://doi.org/10.1002/pd.5014

2017-01-01

Prenatal Diagnosis

Abstract:ObjectiveThe aim of the study was to determine the contribution and significance of maternal copy number variations (CNVs) to false-positive noninvasive prenatal testing (NIPT) trisomy results.MethodsA total of 112021 patients were referred for NIPT. Fetal aneuploidy testing was performed using low coverage massively parallel sequencing, and results reported as chromosome Z-scores. Copy number variation sequencing (CNV-Seq) was used to detect maternal DNA CNVs.ResultsConfirmatory amniocentesis and karyotyping of 563 of 781 patients (72%) receiving a positive trisomy result revealed 489 true and 74 false positives. In 6 of these 74 patients (8.1%), CNV-Seq revealed non-pathogenic maternal duplications (1.76-10.90megabases) on the chromosome associated with the fetal trisomy. There was a strong correlation of higher Z-scores with increasing size of the maternal CNVs (R-2=0.94). When the contribution of the maternal CNV-Seq reads to chromosome Z-scores were removed, all original Z-scores shifted to the normal range.ConclusionsMaternal CNVs can potentially contribute to a small but significant number of false-positive fetal trisomies detected by NIPT. To avoid unnecessary invasive procedures and better manage patients, we recommend that confirmatory maternal DNA sequencing is performed when the NIPT methodology used indicates a high risk of a maternal CNV. (c) 2017 John Wiley & Sons, Ltd.